Novel biologics for cancer therapy

  • Internal Funding

Methods and applications of semi-permeable capsules with current application to high-throughput single cell multi-omics

  • Federal/Foundations Funding

  • Federal/Foundations Funding

  • Internal Funding

Developing novel therapeutic approaches for CNS drug delivery by targeting a newly identified key regulator of the blood brain barrier

  • Internal Funding

  • Internal Funding

Computationally designed therapy targeting lysosomal function and inflammation in neurodegenerative diseases

  • Federal/Foundations Funding

  • New Company/VC

  • Industry Sponsored Research

Restoring cortical function and plasticity for the treatment of Alzheimer’s Disease

  • Federal/Foundations Funding

Microtubule stabilizing drugs for neurodegenerative disease and spinal cord injury

  • Federal/Foundations Funding

Developing therapeutics for treating Rett syndrome by correcting neuronal long-gene misregulation – Lead compound optimization and in vivo validation

  • Federal/Foundations Funding

Building better screens and identifying ligands for human MS4A proteins

  • Federal/Foundations Funding

Development of small molecule modulators of autophagy and ER stress as novel therapeutics for AD

  • New Company/VC

  • Industry Sponsored Research

Developing CRISPR-Cas9 reagents for editing lytic and latent herpes simplex virus genomes

  • Federal/Foundations Funding

Targeting neuro-immune signaling to treat bacterial infections

  • Industry Sponsored Research

Isoguvacine and benzodiazepine derivatives for the treatment of tactile hypersensitivity and anxiety in autism spectrum disorders

  • New Company/VC

  • Industry Sponsored Research

  • Federal/Foundations Funding

  • New Company/VC

  • Industry Sponsored Research

Development of an inexpensive at-home influenza kit and detection technology

  • New Company/VC

  • Industry Sponsored Research

  • Federal/Foundations Funding

  • Federal/Foundations Funding

Development of AAV-mediated mini-gene therapy for Usher syndrome type 1F, a combined deafness and blindness

  • Federal/Foundations Funding

  • Federal/Foundations Funding

  • Industry Sponsored Research

  • Internal Funding

Development of a new precision therapeutic for an important cancer target

  • Federal/Foundations Funding

Targeting apoptotic pathways for ALS, Alzheimer’s Disease and Parkinson’s Disease

  • Federal/Foundations Funding

  • Internal Funding

Next-generation AAV therapies for management of intractable chronic pain

  • Internal Funding

  • Federal/Foundations Funding

Engineered proteins for treatment of pancreatitis

  • Internal Funding

Development of synthetic analogs of a sleeve gastrectomy-induced metabolite as a novel therapy for type 2 diabetes and obesity

  • Federal/Foundations Funding

A high-throughput platform for the non-invasive intracellular delivery of molecules for therapeutic applications

  • New Company/VC

  • Industry Sponsored Research

Target identification of neuroprotective kinase inhibitors for Alzheimer’s and related dementias

  • Industry Sponsored Research

Identifying novel therapeutic targets for treating pain and chronic itch

  • Industry Sponsored Research

A novel biologic and therapeutic target for the treatment of diabetes

  • Internal Funding

A natural beta interferon-inducing therapeutic glycolipid from the microbiome that prevents and treats severe viral infection

  • Federal/Foundations Funding